Psychoemotional disorders of patients with inflammatory bowel diseases: prevalence, pathogenesis and treatment options
- Authors: Bakulin I.G.1, Stamboltsyan V.S.1, Oganezova I.A.1
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Issue: Vol 27, No 2 (2023)
- Pages: 23-31
- Section: Review
- Submitted: 12.03.2023
- Accepted: 14.03.2023
- Published: 20.07.2023
- URL: https://journals.eco-vector.com/RFD/article/view/321284
- DOI: https://doi.org/10.17816/RFD321284
- ID: 321284
Cite item
Abstract
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, according to the World Gastroenterological Organization occupy one of the leading places in the structure of diseases of the gastrointestinal tract of the rate of spread and relevance of research in most countries of the world. The currently existing therapy regimens, which are standardized depending on the form of the disease and the severity of the course, do not take into account the psycho-emotional component of the disease. Progressive course, frequent exacerbations, restriction of social activity, the presence of extra-intestinal manifestations and complications lead to early disability and significantly worsen the quality of life of patients with inflammatory bowel disease.
Full Text
About the authors
Igor G. Bakulin
North-Western State Medical University named after I.I. Mechnikov
Email: igbakulin@yandex.ru
ORCID iD: 0000-0002-6151-2021
SPIN-code: 5283-2032
Scopus Author ID: 6603812937
ResearcherId: P-4453-2014
MD, Dr. Sci. (Med.), Professor
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015Venera Sh. Stamboltsyan
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: stamboltsyan95@mail.ru
ORCID iD: 0000-0002-0134-8856
SPIN-code: 4965-6390
MD
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015Inna A. Oganezova
North-Western State Medical University named after I.I. Mechnikov
Email: oganezova@rambler.ru
ORCID iD: 0000-0003-0844-4469
SPIN-code: 4981-9153
MD, Dr. Sci. (Med.), Professor
Russian Federation, 41 Kirochnaya St., Saint Petersburg, 191015References
- Inflammatory Bowel Disease [Internet]. World Gastroenterology Organisation. Available from: https://www.worldgastroenterology.org/guidelines/inflammatory-bowel-disease-ibd. Accessed: 25.05.2023.
- Klinicheskie rekomendatsii “Yazvennyy kolit” [Internet]. Available from: https://legalacts.ru/doc/klinicheskie-rekomendatsii-iazvennyikolit-utv-minzdravom-rossii. Accessed: 18.09.2021. (In Russ.)
- Ivashkin VT, Shelygin YuA, Abdulganieva DI, et al. Crohn’s disease. Clinical recommendations (preliminary version). Koloproktologia. 2020;19(2(72)):8–38. (In Russ.) doi: 10.33878/2073-7556-2020-19-2-8-38
- Knyazev OV, Shkurko TV, Fadeyeva NA, et al. Epidemiology of chronic inflammatory bowel disease. Yesterday, today, tomorrow. Experimental and Clinical Gastroenterology. 2017;139(3):4–12. (In Russ.)
- Bakulin IG, Skalinskaya MI, Skazyvaeva EV. North-Western register of patients with inflammatory bowel diseases: achievements and lessons learned. Koloproktologia. 2022;21(1):37–49. (In Russ.) doi: 10.33878/2073-7556-2022-21-1-37-49
- Bakulin IG, Skalinskaya MI, Maev IG, et al. Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management. Тerapevticheskii Arkhiv. 2021;8(93):841–852. (In Russ.) doi: 10.26442/00403660.2021.08.200982
- Keller R, Mazurak N, Fantasia L, et al. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res. 2021;19(1):45–52. doi: 10.5217/ir.2019.00135
- Knowles SR, Graff LA, Wilding H, et al. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-Part I. Inflamm Bowel Dis. 2018;4(24):742–751. doi: 10.1093/ibd/izx100
- Maev IV, Shelygin YuA, Skalinskaya MI, et al. Pathomorphosis of inflammatory bowel diseases. Annals of the Russian Academy of Medical Sciences. 2020;75(1):27–35. (In Russ.) doi: 10.15690/vramn1219
- Ozer M, Bengi G, Colak R, et al. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life. Medicine (Baltimore). 2020;99(19):e20067. doi: 10.1097/MD.0000000000020067
- Alexander F. Psychosomatic medicine. Principles and application. Transl. by A.M. Bokovikov, V.V. Starovoitov. Ed. by S.L. Shishkin. Moscow; 2006. (In Russ.)
- James PH, Jessica MM, Sriparna G, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603–621. doi: 10.1002/cphy.c150015
- Martin-Subero M, Anderson G, Kanchanatawan B, et al. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr. 2016;21(2):184–198. doi: 10.1017/S1092852915000449
- Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–148. doi: 10.1016/j.jcmgh.2018.04.003
- Ilchmann-Diounou H, Menard S. Psychological stress, intestinal barrier dysfunctions, and autoimmune disorders: an overview. Front Immunol. 2020;11:133–148. doi: 10.3389/fimmu.2020.01823
- Psikhosomaticheskie rasstroistva v praktike terapevta. (authors) Vinokur V.A., Grinevich V.B., Il’yashevich I.G. et al. Saint Petersburg: SpecLit; 2008. P. 65–84. (In Russ.)
- Sinniger V, Pellissier S, Fauvelle F, et al. A 12-month pilot study outcomes of vagus nerve stimulation in Crohn’s disease. Neurogastroenterol Motil. 2018;32(10):e13911. doi: 10.1111/nmo.13911
- Ge L, Liu S, Li S, et al. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications. Front Immunol. 2022;13:1016578. doi: 10.3389/fimmu.2022.1016578
- Meroni E, Stakenborg N, Gomez-Pinilla PJ, et al. Vagus nerve stimulation promotes epithelial proliferation and controls colon monocyte infiltration during DSS-induced colitis. Front Med (Lausanne). 2021;8:694268. doi: 10.3389/fmed.2021.694268
- Chen LM, Bao CH, Wu Y, et al. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflammation. 2021;18(1):135. doi: 10.1186/s12974-021-02175-2
- Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13(1):3–10. doi: 10.1016/j.autrev.2013.06.004
- Byrne G, Rosenfeld G, Leung Y, et al. Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2017;2017:6496727. doi: 10.1155/2017/6496727
- Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006;12(8):697–707. doi: 10.1097/00054725-200608000-00005
- Yongwen NgJ, Chauhan U, Armstrong D, et al. Comparison of the prevalence of anxiety and depression between uncomplicated and complex IBD patient groups. Gastroenterol Nurs. 2018;41(5):427–435. doi: 10.1097/SGA.0000000000000338
- Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2018;22(3):752–762. doi: 10.1097/MIB.0000000000000620
- Stamboltsyan VSh. Otsenka urovnya ispytuemogo stressa i ehmotsional’noi ustoichivosti u bol’nykh s vospalitel’nymi zabolevaniyami kishechnika. Proceedings of the all-Russian scientific and practical conference with international participation “Mechnikov readings”; Saint Petersburg: 25–26 Apr 2018. Saint Petersburg; 2018. P. 98. (In Russ.)
- Lewis K, Marrie RA, Bernstein CN, et al. The Prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(10):1674–1680. doi: 10.1093/ibd/izz045
- Romasenko LV, Makhov VM, Isaykina MA. Disorders of the anxiety-depressive spectrum in inflammatory bowel diseases (psychosomatic correlations). S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(4):9–13. (In Russ.) doi: 10.17116/jnevro20191190419
- Yuan X, Chen B, Duan Z, et al. Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes. 2021;13(1):1987779. doi: 10.1080/19490976.2021.1987779
- Araki M, Shinzaki S, Yamada T, et al. Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study. PLoS One. 2020;5(15):e0233365. doi: 10.1371/journal.pone.0233365
- Paulides E, Boukema I, van der Woude CJ, de Boer NKH. The Effect of psychotherapy on quality of life in IBD patients: a systematic review. Inflamm Bowel Dis. 2021;27(5):711–724. doi: 10.1093/ibd/izaa144
- Iskandar HN, Cassell B, Kanuri N, et al. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol. 2014;48(5):423–429. doi: 10.1097/MCG.0000000000000049
- Guemei AA, El Din NM, Baraka AM, El Said Darwish I. Do desipramine [10,11-Dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b, f]azepine monohydrochloride] and Fluoxetine [N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats? J Pharmacol Exp Ther. 2008;327(3):846–850. doi: 10.1124/jpet.108.141259
- Kristensen MS, Kjærulff TM, Ersbøll AK, et al. The influence of antidepressants on the disease course among patients with Crohn’s disease and ulcerative colitis-A Danish Nationwide Register-Based Cohort Study. Inflamm Bowel Dis. 2019;25(5):886–893. doi: 10.1093/ibd/izy367